Monopar Therapeutics Inc. (MNPR)
NASDAQ: MNPR · Real-Time Price · USD
35.10
-4.32 (-10.96%)
At close: May 12, 2025, 4:00 PM
35.10
0.00 (0.00%)
After-hours: May 12, 2025, 4:00 PM EDT

Monopar Therapeutics Market Cap

Monopar Therapeutics has a market cap or net worth of $215.77 million as of May 12, 2025. Its market cap has increased by 1,781.55% in one year.

Market Cap
215.77M
Enterprise Value
180.75M
1-Year Change
1,781.55%
Ranking
Category
Stock Price
$35.10

Market Cap Chart

Since December 19, 2019, Monopar Therapeutics's market cap has decreased from $276.16M to $215.77M, a decrease of -21.86%. That is a compound annual growth rate of -4.47%.

History

DateMarket Cap% Change
May 9, 2025240.96M79.60%
Dec 31, 2024134.17M2,552.79%
Dec 29, 20235.06M-83.48%
Dec 30, 202230.62M-24.23%
Dec 31, 202140.42M-42.33%
Dec 31, 202070.09M-59.48%
Dec 31, 2019 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 659.45B
Johnson & Johnson 371.06B
UnitedHealth Group 345.29B
AbbVie 326.08B
Novo Nordisk 297.79B
Abbott Laboratories 231.82B
Novartis AG 214.71B
AstraZeneca 211.14B
Market Cap Rankings